These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 2467380

  • 21. Effect of beta-cyclodextrin on the degradation rate of cinnarizine in aqueous solution.
    Tokumura T, Tatsuishi K, Kayano M, Machida Y, Nagai T.
    Chem Pharm Bull (Tokyo); 1985 May; 33(5):2079-83. PubMed ID: 4053231
    [No Abstract] [Full Text] [Related]

  • 22. Heparin derivatives as angiogenesis inhibitors.
    Presta M, Leali D, Stabile H, Ronca R, Camozzi M, Coco L, Moroni E, Liekens S, Rusnati M.
    Curr Pharm Des; 2003 May; 9(7):553-66. PubMed ID: 12570803
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Anti-tumor and anti-angiogenic effects in mice of heparin conjugated to angiostatic steroids.
    Derbyshire EJ, Comin GA, Yang YC, Overholser J, Watkins L, Thorpe PE.
    Int J Cancer; 1995 Nov 27; 63(5):694-701. PubMed ID: 7591287
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of angiostatic steroid with or without glucocorticoid activity on metastasis.
    Sakamoto N, Tanaka NG.
    Invasion Metastasis; 1987 Nov 27; 7(4):208-16. PubMed ID: 2444551
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Enhanced bioavailability of phenytoin by beta-cyclodextrin complexation (author's transl].
    Tsuruoka M, Hashimoto T, Seo H, Ichimasa S, Ueno O, Fujinaga T, Otagiri M, Uekama K.
    Yakugaku Zasshi; 1981 Apr 27; 101(4):360-7. PubMed ID: 7288580
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effect of sulfated beta-cyclodextrin, a water soluble cycloamylose, on the promotion and/or inhibition of angiogenesis.
    Strauss L, Fuenzalida M, Illanes J, Dabancens A, Díaz E, Lemus D, Guerrero A.
    Pathol Oncol Res; 2002 Apr 27; 8(1):47-53. PubMed ID: 11994763
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Heptakis(2,6-O-dimethyl)beta-cyclodextrin: a novel growth stimulant for Bordetella pertussis phase I.
    Imaizumi A, Suzuki Y, Ono S, Sato H, Sato Y.
    J Clin Microbiol; 1983 May 27; 17(5):781-6. PubMed ID: 6306047
    [Abstract] [Full Text] [Related]

  • 34. Rescue from hypervitaminosis A or potentiation of retinoid toxicity by different modes of cyclodextrin administration.
    Pitha J, Szente L.
    Life Sci; 1983 Feb 14; 32(7):719-23. PubMed ID: 6827906
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Enhancement of specific biological activity of dipyridamole by complexation with beta-cyclodextrin.
    Fregnan GB, Bertè F.
    Pharmacology; 1990 Feb 14; 40(2):96-102. PubMed ID: 2345776
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Induction of angiogenesis by bovine brain derived class 1 heparin-binding growth factor.
    Lobb RR, Alderman EM, Fett JW.
    Biochemistry; 1985 Sep 10; 24(19):4969-73. PubMed ID: 2416338
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.